Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Planning for retirement at 50 involves several key considerations. Being informed can help ensure a successful transition.
18,815 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
As inflation reaccelerates, a potential rate hike under a new Fed chair could complicate Trump’s midterm plans and ri...
Sea Limited blends e-commerce, gaming, and fintech in Southeast Asia. This article explores whether its stock is a li...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
Mondelez stock inches toward a golden cross as easing cocoa prices and stronger emerging-market demand rally the snac...
Ford’s stock closed at its highest level in three years, powered by AI tie-ups, improving European margins, and robus...
The United States appears to be nearing a practical ceiling in its sanctions campaign against Iran, raising questions...
Bitcoin remains the market benchmark as XRP pushes deeper into cross-border payments. Analysts weigh XRP's growth aga...
A seismic shift is brewing in the card world. Capital One's integration with Discover could turn payment processing i...
Standard Chartered’s chief executive apologized after remarks that some workers are 'lower value' amid a push to auto...
Spot XRP ETFs are gaining momentum in 2026, pulling in about $1.75 billion in cumulative inflows and amassing roughly...